Page last updated: 2024-09-04

rhodioloside and Kidney Neoplasms

rhodioloside has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, ZM; Huang, Y; Liu, ZX; Lv, C; Yu, D	1

Other Studies

1 other study(ies) available for rhodioloside and Kidney Neoplasms

Article	Year
Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling. Cancer biomarkers : section A of Disease markers, 2016, Jun-07, Volume: 17, Issue:1 Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Glucosides; Humans; Janus Kinase 2; Kidney Neoplasms; Male; Mice; Phenols; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2016

Article

Year

Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.

Cancer biomarkers : section A of Disease markers, 2016, Jun-07, Volume: 17, Issue:1

Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Glucosides; Humans; Janus Kinase 2; Kidney Neoplasms; Male; Mice; Phenols; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2016